Publication:
Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells

dc.contributor.authorWisessmith W.
dc.contributor.authorPhansuwan-Pujito P.
dc.contributor.authorGovitrapong P.
dc.contributor.authorChetsawang B.
dc.date.accessioned2021-04-05T04:33:19Z
dc.date.available2021-04-05T04:33:19Z
dc.date.issued2009
dc.date.issuedBE2552
dc.description.abstractSeveral studies demonstrated that methamphetamine (MA)-treated human neuroblastoma cells exhibit increased oxidative stress, which regulates intracellular signaling cascades leading to cell death. Melatonin has a potential as a direct free radical scavenger and protects against cell death caused by MA. The objective of this study was to investigate the neuroprotective properties of melatonin on MA-induced induction of death signaling cascade and neuronal cell degeneration in human neuroblastoma SH-SY5Y cultured cells. The results of the present study demonstrate that MA significantly reduced cell viability in SH-SY5Y cultured cells. Desipramine, a monoamine uptake blocker, and melatonin reversed the toxic effect of MA in reducing cell viability. Induction of Bax, Bcl-2 and cleaved caspase-3 protein levels were observed in SH-SY5Y cultured cells treated with MA, whereas the induction of Bax and cleaved caspase-3 was diminished by melatonin. Visualization of the induction of Bax using immunofluorescence but a reduction in mitochondrial sites using red-fluorescent mitochondria-staining dye was more obviously apparent in MA-treated cells than in untreated control cells and, again, this effect was abolished by melatonin. These findings demonstrate important roles of Bax and caspase in death signaling cascade, and the protective effects of melatonin in MA-treated SH-SY5Y cells. © 2009 Blackwell Munksgaard.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of Pineal Research. Vol 46, No.4 (2009), p.433-440
dc.identifier.doi10.1111/j.1600-079X.2009.00680.x
dc.identifier.issn7423098
dc.identifier.other2-s2.0-64649097900
dc.identifier.urihttps://hdl.handle.net/20.500.14740/6958
dc.rights.holderScopus
dc.subject.otherCaspase 3
dc.subject.otherDesipramine
dc.subject.otherMelatonin
dc.subject.otherMethamphetamine
dc.subject.otherProtein Bax
dc.subject.otherProtein bcl 2
dc.subject.otherArticle
dc.subject.otherCell protection
dc.subject.otherCell viability
dc.subject.otherControlled study
dc.subject.otherEnzyme degradation
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherMitochondrion
dc.subject.otherNerve cell degeneration
dc.subject.otherNerve cell necrosis
dc.subject.otherNeuroblastoma cell
dc.subject.otherNeuroprotection
dc.subject.otherBcl-2-Associated X Protein
dc.subject.otherCaspase 3
dc.subject.otherCell Count
dc.subject.otherCell Death
dc.subject.otherCell Line, Tumor
dc.subject.otherCell Survival
dc.subject.otherDesipramine
dc.subject.otherDrug Interactions
dc.subject.otherHumans
dc.subject.otherMelatonin
dc.subject.otherMethamphetamine
dc.subject.otherMicroscopy, Fluorescence
dc.subject.otherMitochondria
dc.subject.otherNeuroblastoma
dc.subject.otherNeuroprotective Agents
dc.subject.otherSignal Transduction
dc.titleMelatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-64649097900&doi=10.1111%2fj.1600-079X.2009.00680.x&partnerID=40&md5=57ed2cf999800e2d2083ca22bf6f2222

Files